The Food and Drug Administration inspected Lifebanc in Warrensville Heights on April 21 for procedures related to human cellular, tissue, and gene therapies, according to data posted on the FDA’s website.
The inspection’s final report stated that Lifebanc was not required to make any corrections to its management operations.
The FDA regularly inspects facilities throughout the country to confirm their workplaces and products follow FDA-regulated laws designed to support public health. Findings from these inspections are made available to the public.
Its website explains that the FDA is a federal agency chiefly tasked with overseeing the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
